Towards Healthcare
U.S. Cardiac Ablation Market to Rise at 14.19% GAGR till 2034

U.S. Cardiac Ablation Market Future Shaped by AI Trends

According to market projections, the U.S. cardiac ablation sector is expected to grow from USD 1.92 billion in 2024 to USD 7.2 billion by 2034, reflecting a CAGR of 14.19%. The U.S. cardiac ablation market is expanding due to growth in the aging population as well as rising innovations. The Northeast U.S. led the market due to the growing awareness.

Content

  • Insight Code: 6209
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The U.S. cardiac ablation market in 2025 is valued at USD 2.19 billion and is projected to climb to USD 7.2 billion by 2034, with a CAGR of 14.19% over the forecast period.

The Northeast U.S. is currently leading the U.S. cardiac ablation market share by 30% due to the growing awareness.

The U.S. cardiac ablation market includes five segments such as by product type, by application/arrhythmia type, by end user, by energy source, and by region (U.S.).

The cardiac ablation is used for the management of atrial fibrillation (AF), atrial flutter, supraventricular tachycardia (SVT), and ventricular tachycardia (VT).

Growing technological innovations are the factor that drives the market growth.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions